Puracap Pharm`s Generic Omega-3-Acid Ethyl Esters Receives Approval in US
Puracap Pharm's Generic Benzonatate Receives Approval in US
Puracap Pharma`s Generic Ergocalciferol Receives Approval in US
PuraCap`s Generic Pioglitazone Hydrochloride Receives Approval In US
US regulators are satisfied a soft gelatin capsule plant in Wuhan, China is up to code according to Puracap Pharmaceutical LLC.
PuraCap Pharmaceutical LLC announced today the introduction of two new acne products in their Eptex™ line of intelligent, physiologic skin repair formulations, Eptex Controlled Release Acne Wash and Eptex Controlled Release Acne Relief Lotion. The Eptex non-prescription acne product line utilizes cutting-edge delivery systems and proven ingredients to effectively treat acne for patients with sensitive skin, and is available through healthcare professionals. PuraCap is the maker of EpiCeram® Controlled Release Skin Barrier Emulsion, a leading prescription product indicated for atopic dermatitis and related skin conditions. The introduction of Eptex acne products adds to PuraCap's growing portfolio of dermatology products.
Generics maker PuraCap is beefing up its manufacturing, buying out a Kentucky company that has a solid-dose manufacturing plant in Puerto Rico as it looks to expand its reach internationally.
Puracap`s Generic Memantine Hydrochloride approved in US for Dementia
PuraCap Pharmaceutical LLC is pleased to announce that the US Food and Drug Administration (FDA) has completed a successful inspection of its affiliated soft gelatin capsule manufacturing facility, Humanwell PuraCap Pharmaceutical (Wuhan) Co, Ltd, located in Wuhan, Hubei Province China. The inspection confirmed that the site is compliant with Current Good Manufacturing Practices, and NO Form 483 observations were issued. This FDA inspection took place on May 18 through May 22, 2015.
PuraCap Pharmaceutical LLC announced today the introduction of a new product, EpiCeram-L™ Lip Care, a unique lip care formulation with an exclusive delivery system for the treatment of dry lip conditions. PuraCap Pharmaceutical is the maker of EpiCeram® Controlled Release Skin Barrier Emulsion, a leading prescription product indicated for the treatment of dry skin conditions and management of burning and itching associated with various skin conditions including atopic dermatitis. The introduction of EpiCeram-L adds to PuraCap's growing portfolio of dermatology products.